A phase II study of sunitinib as a second-line treatment in advanced biliary tract carcinoma: a multicentre, multinational study (Q33398787)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
A phase II study of sunitinib as a second-line treatment in advanced biliary tract carcinoma: a multicentre, multinational study
scientific article

    Statements

    A phase II study of sunitinib as a second-line treatment in advanced biliary tract carcinoma: a multicentre, multinational study (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit